Blackstone, Bain Capital Among Final Bidders for Mitsubishi Tanabe Pharma
Blackstone, Bain Capital, and JIP are final bidders for Mitsubishi Tanabe Pharma, potentially valuing the deal at $3-3.5 billion. The acquisition of the Japanese pharmaceutical company highlights growing global interest in the sector.
Blackstone, Bain Capital Among Final Bidders for Mitsubishi Tanabe Pharma Read More »